|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1001 G STREET, NW |
Address2 | SUITE 900 EAST |
| City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 31680-797
|
||||||||
|
6. House ID# 311100273
|
||||||||
| TYPE OF REPORT | 8. Year | 2010 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Kimberley Fritts, CEO |
Date | 01/20/2011 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Pandemic Flu Funding, TMTI Program
H.R. 4899 Supplemental Appropriations Act, 2010
S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011
S. 3800 Department of Defense Appropriations Act, 2011
H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322
H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-317
H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Cohen |
|
|
|
Thomas |
Sparkman |
|
|
|
John |
Scofield |
|
Comm. Director, House Appropriations Cmte. |
|
John |
Scofield |
|
Press Secretary, Rep Frank LoBiondo |
|
John |
Scofield |
|
Asst. Press Secretary, Sen. Mark Hatfield |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Vaccine Issues
Pandemic Influenza
P.L. 111-148 Patient Protection and Affordable Care Act
P.L. 111-152 Health Care and Education Reconciliation Act of 2010
H.R. 3081 Continuing Appropriations Act, 2011
H.R. 4899 Supplemental Appropriations Act, 2010 (Pandemic Flu Funding Provision)
S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011(Pandemic Flu)
S. 3800 Department of Defense Appropriations Act, 2011(TMTI Provision, Pandemic Flu)
H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010
H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322
H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-317
H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Cohen |
|
|
|
Thomas |
Sparkman |
|
|
|
John |
Scofield |
|
Comm. Director, House Appropriations Cmte. |
|
John |
Scofield |
|
Press Secretary, Rep. Frank LoBiondo |
|
John |
Scofield |
|
Asst. Press Secretary, Sen. Mark Hatfield |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
TMTI Program
H.R. 4899 Supplemental Appropriations Act, 2010
S. 3800 Department of Defense Appropriations Act, 2011(TMTI Provision, Pandemic Flu)
H.R. 3081 Continuing Appropriations Act, 2011
H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322
H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-317
H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Cohen |
|
|
|
Thomas |
Sparkman |
|
|
|
John |
Scofield |
|
Comm. Director, House Appropriations Cmte. |
|
John |
Scofield |
|
Press Secretary, Rep. Frank LoBiondo |
|
John |
Scofield |
|
Asst. Press Secretary, Sen. Mark Hatfield |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010
H.R. 4899 Supplemental Appropriations Act, 2010 (Pandemic Flu Funding Provision)
H.R. 4849 Small Business and Infrastructure Jobs Tax Act of 2010
4)H.R. 4994, Medicare and Medicaid Extenders Act of 2010; P.L. 111-309
H.R. 5712, The Physician Payment and Therapy Relief Act of 2010; P.L. 111-286
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Cohen |
|
|
|
Thomas |
Sparkman |
|
|
|
John |
Scofield |
|
Comm. Director, House Appropriations Cmte. |
|
John |
Scofield |
|
Press Secretary, Rep. Frank LoBiondo |
|
John |
Scofield |
|
Asst. Press Secretary, Sen. Mark Hatfield |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address | |
||||||
| City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
| City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |